PRESS RELEASE published on 02/24/2026 at 15:27, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% stake in Beazley plc. Details of the ownership disclosed according to Code Rule 8.3 Vanguard Group Ownership Disclosure Stake Code Rule 8.3 Beazley Plc
PRESS RELEASE published on 02/24/2026 at 15:26, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.51% ownership in Schroders plc. Position disclosed on 23 Feb 2026. Details in Form 8.3 The Vanguard Group, Inc. Form 8.3 Schroders Plc Ownership Disclosure Financial Securities
PRESS RELEASE published on 02/24/2026 at 15:26, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 0.94% stake in Life Science REIT plc. Details of securities and derivative transactions provided Vanguard Group Stake Disclosure Securities Transactions Derivative Transactions Life Science REIT Plc
PRESS RELEASE published on 02/24/2026 at 15:25, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% interest in Spire Healthcare Group plc. Purchase of 1p ordinary shares at 1.99 GBP per unit on 23 Feb 2026 Disclosure Vanguard Group Spire Healthcare Purchase GBP
PRESS RELEASE published on 02/24/2026 at 15:24, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.92% stake in Just Group plc. Details on ownership, positions, and dealings provided in Form 8.3 submission Form 8.3 Vanguard Group Dealings Ownership Just Group Plc
PRESS RELEASE published on 02/24/2026 at 15:23, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.30% interest in LondonMetric Property plc on 23 Feb 2026. Purchased 186,849 securities at 2.13 GBP per unit Securities The Vanguard Group, Inc. LondonMetric Property Plc Disclosure Purchase
PRESS RELEASE published on 02/24/2026 at 15:23, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.24% ownership in Picton Property Income Limited, making a purchase of 37,802 securities at 0.87 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Picton Property Income Limited
PRESS RELEASE published on 02/24/2026 at 15:22, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.83% ownership in NCC Group plc. No other party disclosures. Purchase of 1p ordinary securities at 1.29 GBP per unit Vanguard Group Ownership Disclosure Securities Purchase 1p Ordinary NCC Group Plc
PRESS RELEASE published on 02/24/2026 at 15:21, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. discloses a 5.45% stake in British Land Company plc. Details on securities holdings and dealings provided in Form 8.3 Form 8.3 Vanguard Group Dealings Securities Holdings British Land Company Plc
PRESS RELEASE published on 02/24/2026 at 15:20, 6 months 14 days ago NextSource Materials Announces Closing of $25 Million LIFE Offering to Advance UAE Battery Anode Facility NextSource Materials Inc. closes oversubscribed private placement offering of Units for C$24,999,987 to advance projects and for general corporate purposes Private Placement Offering Units Battery Materials NextSource Materials Inc. Investor Demand
Published on 09/11/2026 at 04:00, 5 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 20 minutes ago Availability of the 2026 Interim Financial Report
